IBDEI0N9 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10626,0)
 ;;=R80.8^^68^671^88
 ;;^UTILITY(U,$J,358.3,10626,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10626,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,10626,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,10626,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,10627,0)
 ;;=R80.3^^68^671^84
 ;;^UTILITY(U,$J,358.3,10627,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10627,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,10627,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,10627,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,10628,0)
 ;;=R80.9^^68^671^89
 ;;^UTILITY(U,$J,358.3,10628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10628,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,10628,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,10628,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,10629,0)
 ;;=Z87.442^^68^671^77
 ;;^UTILITY(U,$J,358.3,10629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10629,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,10629,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,10629,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,10630,0)
 ;;=N18.1^^68^671^13
 ;;^UTILITY(U,$J,358.3,10630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10630,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,10630,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,10630,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,10631,0)
 ;;=N18.2^^68^671^14
 ;;^UTILITY(U,$J,358.3,10631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10631,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,10631,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,10631,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,10632,0)
 ;;=N18.3^^68^671^15
 ;;^UTILITY(U,$J,358.3,10632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10632,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,10632,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,10632,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,10633,0)
 ;;=N18.4^^68^671^16
 ;;^UTILITY(U,$J,358.3,10633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10633,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,10633,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,10633,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,10634,0)
 ;;=N18.5^^68^671^17
 ;;^UTILITY(U,$J,358.3,10634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10634,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,10634,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,10634,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,10635,0)
 ;;=Q61.3^^68^671^80
 ;;^UTILITY(U,$J,358.3,10635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10635,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,10635,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,10635,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,10636,0)
 ;;=N20.1^^68^671^9
 ;;^UTILITY(U,$J,358.3,10636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10636,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,10636,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,10636,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,10637,0)
 ;;=N18.9^^68^671^18
 ;;^UTILITY(U,$J,358.3,10637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10637,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,10637,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,10637,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,10638,0)
 ;;=N18.6^^68^671^28
 ;;^UTILITY(U,$J,358.3,10638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10638,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,10638,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,10638,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,10639,0)
 ;;=N52.9^^68^671^44
 ;;^UTILITY(U,$J,358.3,10639,1,0)
 ;;=^358.31IA^4^2
